サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1459785

神経科学市場：世界の産業分析、規模、シェア、成長、動向、2023年～2031年予測

Neuroscience Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 182 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
神経科学市場：世界の産業分析、規模、シェア、成長、動向、2023年～2031年予測
出版日: 2024年02月28日
発行: Transparency Market Research
ページ情報: 英文 182 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経科学市場- 調査範囲

TMRの世界の神経科学市場に関する調査レポートは、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの神経科学の世界市場の収益と予測を提供します。また、2023年から2031年までの神経科学の世界市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、神経科学市場を理解するために主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照しました。

市場スナップショット
2022年の市場規模 301億米ドル
2031年の市場価値 416億米ドル
CAGR 3.7%

本レポートでは、世界の神経科学市場の競合情勢について掘り下げています。神経科学の世界市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイリングされています。企業概要、財務状況、最近の発展、SWOTが本レポートに掲載されている神経科学の世界市場における企業の属性です。

目次

第1章 序文

第2章 調査前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 世界市場の分析と予測、2017年～2031年

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要M&A
  • COVID-19パンデミックの産業への影響

第6章 世界市場分析と予測：コンポーネント別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：コンポーネント別、2017年～2031年
    • 機器
    • ソフトウェア
    • サービス
  • 市場魅力度分析：コンポーネント別

第7章 世界市場分析・予測：技術別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：技術別、2017年～2031年
    • 全脳イメージング
    • 神経顕微鏡
    • 電気生理学
    • ニューロプロテオミクス分析
    • 動物行動解析
    • 神経機能解析
    • その他
  • 市場魅力度分析：技術別

第8章 世界市場分析・予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2017年～2031年
    • 病院
    • 診断研究所
    • 学術・研究機関
    • その他
  • 市場魅力度分析：技術別

第9章 世界市場分析・予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017年～2031年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と展望

第14章 中東・アフリカ市場の分析と展望

第15章 競争環境競合情勢

  • 市場競合マトリックス（ティア別、企業規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • NEURALINK
    • Kernel
    • BrainCo, Inc.
    • MindMaze
    • Paradromics
    • NeuroPro
    • NeuroSky
    • EMOTIV, Inc.
    • Cercare Medical A/S
    • Plexon, Inc.
    • Noldus Information Technology B.V.
    • Femtonics Ltd.
    • Neuralynx, Inc.
    • Neurable, Inc.
    • Bitbrain Technologies
    • Halo
    • NeuroNexus Technologies, Inc.
図表

List of Tables

  • Table 01: Global Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 02: Global Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Neuroscience Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Neuroscience Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 07: North America Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 08: North America Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 11: Europe Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 12: Europe Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 15: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 16: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 19: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 20: Latin America Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017-2031
  • Table 23: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 24: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Neuroscience Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Neuroscience Market Revenue (US$ Mn), by Component, 2022
  • Figure 03: Global Neuroscience Market Value Share, by Component, 2022
  • Figure 04: Global Neuroscience Market Revenue (US$ Mn), by Technology, 2022
  • Figure 05: Global Neuroscience Market Value Share, by Technology, 2022
  • Figure 06: Global Neuroscience Market Revenue (US$ Mn), by End-user, 2022
  • Figure 07: Global Neuroscience Market Value Share, by End-user, 2022
  • Figure 08: Global Neuroscience Market Value Share, by Region, 2022
  • Figure 09: Global Neuroscience Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 11: Global Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 12: Global Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 13: Global Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 14: Global Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 15: Global Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 16: Global Neuroscience Market Value Share Analysis, by Region, 2022-2031
  • Figure 17: Global Neuroscience Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Neuroscience Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Neuroscience Market Value Share Analysis, by Country, 2022-2031
  • Figure 21: North America Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 22: North America Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 23: North America Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 24: North America Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 25: North America Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 26: North America Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 30: Europe Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 31: Europe Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 32: Europe Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 33: Europe Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 34: Europe Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 35: Europe Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Asia Pacific Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 39: Asia Pacific Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 40: Asia Pacific Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 41: Asia Pacific Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 42: Asia Pacific Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 43: Asia Pacific Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 44: Asia Pacific Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 48: Latin America Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 49: Latin America Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 50: Latin America Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 51: Latin America Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 52: Latin America Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 53: Latin America Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 57: Middle East & Africa Neuroscience Market Value Share Analysis, by Component, 2022-2031
  • Figure 58: Middle East & Africa Neuroscience Market Value Share Analysis, by Technology, 2022-2031
  • Figure 59: Middle East & Africa Neuroscience Market Value Share Analysis, by End-user, 2022-2031
  • Figure 60: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Component, 2023-2031
  • Figure 61: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 62: Middle East & Africa Neuroscience Market Attractiveness Analysis, by End-user, 2023-2031
目次
Product Code: TMRGL49641

Neuroscience Market - Scope of Report

TMR's report on the global neurosciences market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global neurosciences market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurosciences market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the neurosciences market.

Market Snapshot
Market Value in 2022US$ 30.1 Bn
Market Value in 2031US$ 41.6 Bn
CAGR3.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurosciences market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global neurosciences market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurosciences market.

The report delves into the competitive landscape of the global neurosciences market. Key players operating in the global neurosciences market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global neurosciences market profiled in this report.

Key Questions Answered in Global neurosciences Market Report:

  • What is the sales/revenue generated by neurosciences across all regions during the forecast period?
  • What are the opportunities in the global neurosciences market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Neuroscience Market - Research Objectives and Research Approach

The comprehensive report on the global neurosciences market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global neurosciences market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global neurosciences market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Neuroscience Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Neuroscience Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Neuroscience Market Analysis and Forecast, by Component

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Component, 2017-2031
    • 6.3.1. Instrument
    • 6.3.2. Software
    • 6.3.3. Services
  • 6.4. Market Attractiveness Analysis, by Component

7. Global Neuroscience Market Analysis and Forecast, by Technology

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Whole Brain Imaging
    • 7.3.2. Neuro-microscopy
    • 7.3.3. Electrophysiology
    • 7.3.4. Neuroproteomics Analysis
    • 7.3.5. Animal Behavior Analysis
    • 7.3.6. Neuro-functional Analysis
    • 7.3.7. Others
  • 7.4. Market Attractiveness Analysis, by Technology

8. Global Neuroscience Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Academic & Research Institutions
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Technology

9. Global Neuroscience Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Neuroscience Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Component, 2017-2031
    • 10.3.1. Instrument
    • 10.3.2. Software
    • 10.3.3. Services
  • 10.4. Market Value Forecast, by Technology, 2017-2031
    • 10.4.1. Whole Brain Imaging
    • 10.4.2. Neuro-microscopy
    • 10.4.3. Electrophysiology
    • 10.4.4. Neuroproteomics Analysis
    • 10.4.5. Animal Behavior Analysis
    • 10.4.6. Neuro-functional Analysis
    • 10.4.7. Others
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Hospitals
    • 10.5.2. Diagnostic Laboratories
    • 10.5.3. Academic & Research Institutions
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Component
    • 10.7.2. By Technology
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Neuroscience Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Component, 2017-2031
    • 11.3.1. Instrument
    • 11.3.2. Software
    • 11.3.3. Services
  • 11.4. Market Value Forecast, by Technology, 2017-2031
    • 11.4.1. Whole Brain Imaging
    • 11.4.2. Neuro-microscopy
    • 11.4.3. Electrophysiology
    • 11.4.4. Neuroproteomics Analysis
    • 11.4.5. Animal Behavior Analysis
    • 11.4.6. Neuro-functional Analysis
    • 11.4.7. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Academic & Research Institutions
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Component
    • 11.7.2. By Technology
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Neuroscience Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Component, 2017-2031
    • 12.3.1. Instrument
    • 12.3.2. Software
    • 12.3.3. Services
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. Whole Brain Imaging
    • 12.4.2. Neuro-microscopy
    • 12.4.3. Electrophysiology
    • 12.4.4. Neuroproteomics Analysis
    • 12.4.5. Animal Behavior Analysis
    • 12.4.6. Neuro-functional Analysis
    • 12.4.7. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostic Laboratories
    • 12.5.3. Academic & Research Institutions
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Component
    • 12.7.2. By Technology
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Neuroscience Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Component, 2017-2031
    • 13.3.1. Instrument
    • 13.3.2. Software
    • 13.3.3. Services
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. Whole Brain Imaging
    • 13.4.2. Neuro-microscopy
    • 13.4.3. Electrophysiology
    • 13.4.4. Neuroproteomics Analysis
    • 13.4.5. Animal Behavior Analysis
    • 13.4.6. Neuro-functional Analysis
    • 13.4.7. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostic Laboratories
    • 13.5.3. Academic & Research Institutions
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Component
    • 13.7.2. By Technology
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Neuroscience Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Component, 2017-2031
    • 14.3.1. Instrument
    • 14.3.2. Software
    • 14.3.3. Services
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. Whole Brain Imaging
    • 14.4.2. Neuro-microscopy
    • 14.4.3. Electrophysiology
    • 14.4.4. Neuroproteomics Analysis
    • 14.4.5. Animal Behavior Analysis
    • 14.4.6. Neuro-functional Analysis
    • 14.4.7. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostic Laboratories
    • 14.5.3. Academic & Research Institutions
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Component
    • 14.7.2. By Technology
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. NEURALINK
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Kernel
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. BrainCo, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. MindMaze
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Paradromics
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. NeuroPro
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. NeuroSky
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. EMOTIV, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Cercare Medical A/S
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Plexon, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Noldus Information Technology B.V.
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Femtonics Ltd.
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview
    • 15.3.13. Neuralynx, Inc.
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Financial Overview
      • 15.3.13.5. Strategic Overview
    • 15.3.14. Neurable, Inc.
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Product Portfolio
      • 15.3.14.3. SWOT Analysis
      • 15.3.14.4. Financial Overview
      • 15.3.14.5. Strategic Overview
    • 15.3.15. Bitbrain Technologies
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Product Portfolio
      • 15.3.15.3. SWOT Analysis
      • 15.3.15.4. Financial Overview
      • 15.3.15.5. Strategic Overview
    • 15.3.16. Halo Neuroscience
      • 15.3.16.1. Company Overview
      • 15.3.16.2. Product Portfolio
      • 15.3.16.3. SWOT Analysis
      • 15.3.16.4. Financial Overview
      • 15.3.16.5. Strategic Overview
    • 15.3.17. NeuroNexus Technologies, Inc.
      • 15.3.17.1. Company Overview
      • 15.3.17.2. Product Portfolio
      • 15.3.17.3. SWOT Analysis
      • 15.3.17.4. Financial Overview
      • 15.3.17.5. Strategic Overview